Skip to main content

Advertisement

SpringerLink
Log in

Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users

  • Original Article
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Public health agencies have recommended incorporating HIV prevention counseling into the medical care of persons living with HIV/AIDS. Injection drug users (IDUs) especially need HIV risk-reduction counseling because of their high risk for HIV transmission through both sexual and injection behaviors. The objective of this study was to assess the prevalence of, and patient factors associated with, the delivery of HIV prevention messages to HIV-seropositive IDUs in primary care settings. A majority of participants reported having an HIV prevention discussion with their provider during their most recent primary care visit. Factors significantly associated with report of such discussion were being Hispanic or non-Hispanic Black; high school education or less; and better perception of engagement with provider. Medical providers should provide prevention messages to all HIV-seropositive IDUs, regardless of demographic factors. Effective HIV prevention interventions in primary care settings, including interventions to improve patient-provider communication, are needed for HIV-seropositive IDUs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bakken, S., Holzemer, W. L., Brown, M., Powell-Cope, G. M., Turner, J. G., and Inouye, J. (2000). Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care and STDs, 14, 189–197.

    Article  PubMed  CAS  Google Scholar 

  2. Centers for Disease Control and Prevention. (2002). HIV/AIDS Surveillance Report, 14.

  3. Centers for Disease Control and Prevention. (2003). Incorporating HIV prevention into the care of persons living with HIV: Recommendations of the Centers for Disease Control and Prevention, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of America. MMWR Morbidity and Mortality Weekly Reports, 52(RR–12), 1–24.

    Google Scholar 

  4. Deren, S., Beardsley, M., Coyle, S., and Singer, M. (1998). HIV serostatus and risk behaviors in a multisite sample of drug users. Journal of Psychoactive Drugs, 30, 239–245.

    PubMed  CAS  Google Scholar 

  5. Derogatis, L. R., and Spencer, P. M. (1982). The Brief Symptom Inventory (BSI): Administration, scoring, and procedural manual. Baltimore: John Wiley.

    Google Scholar 

  6. Dodge, W. T., BlueSpruce, J., Grothaus, L., Rebolledo, V., McAfee, T. A., and Carey, J. W. (2001). Enhancing primary care HIV prevention: A comprehensive clinical intervention. American Journal of Preventive Medicine, 20, 177–183.

    Article  PubMed  CAS  Google Scholar 

  7. Duffus, W. A., Barragan, M., Metsch, L., Krawczyk, C. S., Loughlin, A. M., and Gardner, L. I. (2003). Effect of physician specialty on counseling practices and medical referral patterns among physicians caring for disadvantaged human immunodeficiency virus–infected populations. Clinical Infectious Diseases, 36, 1577–1584.

    Article  PubMed  CAS  Google Scholar 

  8. Gerbert, B., Brown, B., Volberding, P., Cooke, M., Caspers, N., and Love, C. (1999). Physicians’ transmission prevention assessment and counseling practices with their HIV positive patients. AIDS Education and Prevention, 11, 307–320.

    PubMed  CAS  Google Scholar 

  9. Gerbert, B., Moe, J. C., Saag, M. S., Benson, C. A., Jacobsen, D. M., and Feraios, A. (2001). Toward a definition of HIV expertise: A survey of experienced HIV physicians. AIDS Patient Care and STDs, 15, 321–330.

    Article  PubMed  CAS  Google Scholar 

  10. Marks, G., Richardson, J. L., Crepaz, N., Stoyanoff, S., Milam, J., and Kempker, C. (2002). Are HIV providers talking with patients about safer sex and disclosure?: A multi–clinic assessment. AIDS, 16, 1953–1957.

    Article  PubMed  Google Scholar 

  11. Margolis, A. D., Wolitski, R. J., Parsons, J. T., and Gomez, C. A. (2001). Are healthcare providers talking to HIV–seropositive patients about safer sex? AIDS, 15, 2335–2337.

    Article  PubMed  CAS  Google Scholar 

  12. McGowan, J. P., Shah, S. S., Ganea, C. E., Blum, S., Ernst, J. A., and Irwin, N. K. (2004). Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV–seropositive individuals in an urban setting. Clinical Infectious Diseases, 38, 122–127.

    Article  PubMed  Google Scholar 

  13. Meredith, K. L., Jeffe, D. B., Mundy, L. M., and Fraser, V. J. (2001). Sources influencing patients in their HIV medication decisions. Health Education and Behavior, 28, 40–50.

    PubMed  CAS  Google Scholar 

  14. Metsch, L. R., McCoy, C. B., Lai, S., and Miles, C. (1998). Continuing risk behaviors among HIV–seropositive chronic drug users in Miami, Florida. AIDS and Behavior, 2, 161–169.

    Article  Google Scholar 

  15. Metsch, L. R., Pereyra, M., del Rio, C., Gardner, L., Duffus, W., and Dickinson, G. (2004). Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. American Journal of Public Health, 94, 1186–1192.

    Article  PubMed  Google Scholar 

  16. Morin, S. F., Koester, K. A., Steward, W. T., Maiorana, A., McLaughlin, M., and Myers, J. J. (2004). Missed opportunities: prevention with HIV–infected patients in clinical care settings. Journal of Acquired Immune Deficiency Syndromes, 36, 960–966.

    PubMed  Google Scholar 

  17. Purcell, D. W., Metsch, L. R., Latka, M., Santibanez, S., Gomez, C. A., and Eldred, L. (2004). Interventions for seropositive injectors–research and evaluation: An integrated behavioral intervention with HIV–seropositive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes, 37, S110–S118.

    PubMed  Google Scholar 

  18. Richardson, J. L., Milam, J., McCutchan, A., Stoyanoff, S., Bolan, R., Weiss, J., Kemper, C., Larsen, R. A., Hollander, H., Weismuller, P., Chou, C., and Marks, G. (2004). Effect of brief safer–sex counseling by medical providers to HIV–1 seropositive patients: a multi–clinic assessment. AIDS, 18, 1179–1186.

    Article  PubMed  Google Scholar 

  19. Rogers, E. S., Chamberlin, J., Ellison, M. L., and Crean, T. (1997). A consumer–constructed scale to measure empowerment among users of mental health services. Psychiatric Services, 48, 1042–1047.

    PubMed  CAS  Google Scholar 

  20. Stewart, A. L., and Camberg, C. J. (1992). Physical functioning measures. In: A. L. Stewart, J. E. Ware (Eds.), Measuring functioning and well–being: The medical outcomes study approach (pp. 86–101). Durham: Duke University Press.

    Google Scholar 

  21. Tun, W., Celentano, D. D., Vlahov, D., and Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injection drug users. AIDS, 17, 1953–1962.

    Article  PubMed  Google Scholar 

  22. Weinhardt, L. S., Kelly, J. A., Brondino, M. J., Rotheram–Borus, M. J., Kirshenbaum, S. B., and Chesney, M. A. (2004). HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. Journal of Acquired Immune Deficiency Syndromes, 36, 1057–1066.

    PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Centers for Disease Control and Prevention and the Health Resources and Services Administration (CDC/HRSA grant U50CCU317999). We would also like to acknowledge the following people for their contributions to this research: Baltimore: Susan Sherman, Roeina Marvin, Joanne Jenkins, Donny Gann, Tonya Johnson. Miami: Clyde McCoy, Rob Malow, Wei Zhao, Lauren Gooden, Sam Comerford, Virginia Locascio, Curtis Delford, Laurel Hall, Henry Boza, Cheryl Riles. New York: George Fesser, Carol Gerran, Diane Thornton. San Francisco: Caryn Pelegrino, Barbara Garcia, Jeff Moore, Erin Rowley, Debra Allen, Dinah Iglesia-Usog, Gilda Mendez, Paula Lum, Greg Austin. Centers for Disease Control and Prevention: Gladys Ibanez, Hae-Young Kim, Toni McWhorter, Jan Moore, Lynn Paxton, John Williamson. Centers for Disease Control and Prevention (Laboratory): Lee Lam, Jeanne Urban, Stephen Soroka, Zilma Rey, Astrid Ortiz, Sheila Bashirian, Marjorie Hubbard, Karen Tao, Bharat Parekh, Thomas Spira.

Author information

Authors and Affiliations

  1. Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami, 1801 NW 9th Avenue, Suite 200, Miami, FL, 33136, USA

    James D. Wilkinson, Wei Zhao & Lisa R. Metsch

  2. National Center for HIV, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA

    Scott Santibanez

  3. Department of Medicine, Montefiore Medical Center, Bronx, New York, USA

    Julia Arnsten

  4. Department of Behavior and Health, John Hopkins School of Public Health, Baltimore, MD, USA

    Amy Knowlton

  5. Center for AIDS Prevention Studies, University of California at San Francisco, San Francisco, CA, USA

    Cynthia A. Gómez

Authors
  1. James D. Wilkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott Santibanez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julia Arnsten
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amy Knowlton
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cynthia A. Gómez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lisa R. Metsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

INSPIRE Study Group

Corresponding author

Correspondence to James D. Wilkinson.

Additional information

The INSPIRE Study Group includes the following people. Baltimore: Carl Latkin, Amy Knowlton, Karin Tobin; Miami: Lisa Metsch, Eduardo Valverde, James Wilkinson, Martina DeVarona; New York: Mary, Latka, Dave Vlahov, Phillip Coffin, Marc Gourevitch, Julia Arnsten, Robert Gern; San Francisco: Cynthia Gomez, Kelly Knight, Carol Dawson Rose, Starley Shade, Sonja Mackenzie; Centers for Disease Control and Prevention: David Purcell, Yuko Mizuno, Scott Santibanez, Richard Garfein, ann O’Leary; Health Resources and Services Administration: Lois Eldred, Kathleen Handley

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilkinson, J.D., Zhao, W., Santibanez, S. et al. Providers’ HIV Prevention Discussions with HIV-Seropositive Injection Drug Users. AIDS Behav 10, 699–705 (2006). https://doi.org/10.1007/s10461-006-9088-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-006-9088-4

Key Words

Search

Navigation